猫咪AV成人 Appoints Nora Brennan to Board of Directors and Audit Committee Chair 16 November 2021 | Press release
猫咪AV成人 Doses First Patient in Phase 1/2a Study of Pol胃 Inhibitor ART4215 28 September 2021 | Press release
猫咪AV成人 Announces $153 Million (拢110 Million) Series C Financing Led by Omega Funds and TCG X 27 July 2021 | Press release
猫咪AV成人 Publishes Preclinical Data on The First Selective Small Molecule Pol胃 Polymerase Inhibitor in Nature Communications 17 June 2021 | Press release
猫咪AV成人 Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies 7 April 2021 | Press release
猫咪AV成人 Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients 11 February 2021 | Press release
猫咪AV成人 Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer 12 January 2021 | Press release
Merck KGaA, Darmstadt, Germany and 猫咪AV成人 Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology 3 December 2020 | Press release
猫咪AV成人 Strengthens Clinical Development Team with Senior Appointments 10 February 2020 | Press release